Ashleigh Brooke Mader is a Atlanta, Georgia based nurse practitioner who is specialized as Acute Care nurse. Her current practice location is 5461 Meridian Mark Rd Ste 570, Atlanta. Patients can reach her at 404-785-6895. Ashleigh Brooke Mader is APRN with specialization in Acute Care and her NPI number (Unique professional ID assigned by NPPES) is 1821607409. Ashleigh Brooke Mader is a licensed independent practitioner and may autonomously provide care. She provides advanced nursing care across the continuum of health care services to meet the specialized physiologic and psychological needs of patients with acute, critical, and/or complex chronic health conditions. This care is continuous and comprehensive and may be provided in any setting where the patient may be found.
Complete Profile:
Ashleigh Brooke Mader speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Ashleigh Brooke Mader
Specialization:
Acute Care Nurse Practitioner (ACNP)
Gender:
Female
Credentials:
APRN
Practice Address:
5461 Meridian Mark Rd Ste 570, Atlanta, Georgia, 30342-2807
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1821607409
NPI Enumeration Date:
29 Jul, 2020
NPI Last Update On:
06 Jan, 2022
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Ashleigh Brooke Mader 5461 Meridian Mark Rd Ste 570, Atlanta, Georgia
Zip:
30342-2807
Phone Number:
404-785-6895
Patients can reach Ashleigh Brooke Mader at 5461 Meridian Mark Rd Ste 570, Atlanta, Georgia or can call to book an appointment on 404-785-6895.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.